ABSTRACT Epithelial cells contain desmosomes, special intercellular junctions providing sites of membrane attachment for intermediate-sized filaments of the cytokeratin type (tonofilaments). Such sites of anchorage of tonofilaments appear as dense plaques on the cytoplasmic side ofthe desmosomal membrane. We have isolated desmosome-enriched fractions from bovine snout epidermis and-tongue mucosa and have characterized the major protein associated with the desmosomal plaque. This protein occurs in equimolar amounts oftwo polypeptides OfMr 250,000 (desmoplakin I) and Mr 215,000 (desmoplakin II) which are chemically and immunologically related. Antibodies raised against desmoplakins allow the identification and localization of this protein in epithelial cells grown-in tissues or in vitro and show crossreaction in species as diverse as man, mouse, and chicken. Using immunolocalization at the light and electron microscope levels, we show that these antibodies bind specifically to desmosomal plaques. Antibodies to desmoplakins have been used successfully for detection of desmosomal proteins in a broad variety of epitheliumderived human tumors, including primary carcinomas and their metastases, irrespective of the morphology of the specific tumor. Nonepithelial tumors examined have been negative. We propose to use antibodies to desmoplakins and to cytokeratins in pathological diagnosis as two independent markers for the positive immunocytochemical identification and classification of epithelium derived tumors.
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One ofthe primary problems in tumor diagnosis is correct classification, including identification of the cell type from which the tumor is derived. In many cases, morphological criteria may be sufficient for reaching the correct pathological diagnosis. However, positive identification of the cell type or tissue of origin ofa tumor often is not possible-on the basis ofmorphology alone. This is especially problematic with primary tumors and metastatic lesions that lack special differentiated structures. Recently, antibodies to major components of the cytoskeleton, the intermediate-sized filaments (1) , have been successfully used to distinguish different classes of tumors by nonmorphological criteria. For example, epithelia-derived tumor cells, including carcinomas, contain cytokeratin filaments whereas mesenchymally derived tumors such as sarcomas contain only filaments of the vimentin type (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . This immunocytochemical staining procedure has turned out to be valuable in clinical diagnosis (e.g., refs. 11, 12, and 14) .
One of the remaining problems in the positive identification of carcinomas, however, is the diversity of cytokeratin polypeptides. These differ greatly in Mr (40,000-68,000) and isoelectric pH (4.9-8.5) and are expressed in cell-type-specific patterns (16) (17) (18) (19) . Antibodies to determinants of a certain subgroup ofcytokeratins therefore will not react-with cells lacking these determinants in their specific type of cytokeratin filaments. This could give rise to "false negative" findings (5, 7, 10, 13, 15, 18) . Therefore, we have looked for a compositionally less variable protein common to epithelial cells that might serve as a conservative marker for epithelium-derived tumors.
Epithelial cells contain a special type of intercellular junction, the desmosome (macula adherens). The characteristic ultrastructure of the desmosome as seen in the electron microscope (20) appears as a multilayered array of mirror-image symmetry, dominated by the "midline" structure, the membrane proper, and the dense 14-to 20-nm-thick desmosomal plaque into which the tonofilaments insert. The presence of desmosomal structures is widely used in pathology as an additional criterion for classifying epithelium-derived tumors, notably carcinomas (21) (22) (23) (24) (25) (26) . However, the use of this structure as a positive marker for epithelial and carcinoma cells in routine clinical pathology is problematic for several reasons. (i) The size and morphological appearance ofdesmosomes in many tissues, notably in tumors, can vary considerably. (ii) A wide range of junctional specializations have some structural features in common with typical desmosomes but it is unclear whether these "desmosome-like structures" described in the literature are compositionally related to authentic desmosomes or are other, as yet unclassified, forms of junctions. (iii) Detection of desmosomes requires electron microscopy and therefore is laborious, lengthy, and expensive.
In this paper we describe an approach which overcomes these problems. Use of antibodies to desmoplakin (from the Greek words 8eaEo6s = link, tie, bond, connection and Akaf, irAaKo6 = plate, plaque), a major protein of the desmosomal plaque, allows the detection, at high sensitivity and resolution, of desmosomal proteins in epithelia and tumors derived therefrom.
MATERIALS AND METHODS
Cells and Tissues. Samples of normal human tissues and tumor material were obtained during surgical operations 'and immediately frozen as described (5, 18, 27, 28) . Human and animal (cow, rat, mouse, chicken) tissue samples and cultured bovine (MDBK, BMGE, lens-forming cells), murine (MH1C1, HEL, 3T3), and human (HeLa, A-431, MCF-7, WI-38) cells were processed for immunofluorescence microscopy as described (2, 3, (28) (29) (30) .
Preparation of Antibodies Against Desmoplakins. Desmosome-enriched fractions were isolated from bovine snout epidermis or tongue mucosa by either the citrate buffer procedure (31) or a modification (28) of the low-salt buffer-detergent procedure (32) . Polypeptide bands separated by gel electrophoresis 543 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. were excised, electrophoretically eluted from the gel, and precipitated with acetone (28, 33, 34) . Polypeptide homogeneity of proteins thus prepared was routinely monitored by two-dimensional gel electrophoresis (34) .
Antibodies used in the present study were raised in guinea pigs against excised gel bands containing desmoplakin I, desmoplakin II, and mixtures of the two (Fig. 1 a and Immunolocalization. Immunofluorescence microscopy was performed on cells grown on cover slips or on frozen sections (3, 5, 6, 28, 33) . For comparison, antibodies against cytokeratins (3, 5, 18, 19, 33) and vimentin (2, 29) were used. Electron microscopic localization was done by using the immunoperoxidase procedure (28) . RESULTS Specificity of Antibodies. Guinea pig antibodies raised against bovine desmoplakin I or II or mixtures of I and II (Fig.  lb) reacted, on nitrocellulose blots, with both desmoplakin bands (Fig. 1c) , in agreement with the close similarity of desmoplakins I and II demonstrated by tryptic peptide maps (34) . These antibodies specifically stained the desmosomal plaques identified by immunofluorescence (Fig. Id) and immunoelectron (Fig. 2 ) microscopy, in a fashion similar to a recently described antibody which reacted with some minor desmosomal plaque polypeptides (28) . In immunofluorescence microscopy, individual desmosomes appeared as arrays offluorescent "dots" demarcating cell-to-cell boundaries (Figs. Id and 3a) . Sometimes positively stained dots were also seen away from the lateral cell membrane contacts, and such sites have been correlated with hemidesmosomes at the bottom surface or with endocytotically internalized desmosomal domains (28, 36) .
The antibodies to desmoplakins used in this study showed crossreaction with desmosomal proteins of human (Fig. 3a) , murine, and chicken cells. Desmoplakin antibodies were specific for epithelial cells but also reacted with the desmosomelike junctions in intercalated disks of myocardiac cells and cultured cardiac myocytes (34) . Positive cell lines were MDBK, BMGE, MH1C1, HEL, HeLa, A-431, and MCF-7. All other cell lines examined (lens-forming cells, 3T3, rat RVF smooth muscle, and WI-38) were negative. In certain epithelial cell cultures which formed intercellular bridges (A-431, BMGE, HEL) only the central portions of the bridges-i.e., the desmosomes proper-were stained whereas antibodies to cytokeratins stained the attached tonofilament bundles but not the desmosomes (Fig. 3) .
When examined on frozen sections of human tissues, antibodies to desmoplakins stained plasma membranes ofepithelial cells (Fig. 4) Reaction of Desmoplaldn Antibodies on Tumor Sections. Epithelium-derived human tumors were invariably stained by desmoplakin antibodies, usually revealing dotted arrays on cellto-cell boundaries. This was found for differentiated nonmetastatic tumors such as basal cell epithelioma, myoepithelial-like cells of pleomorphic adenoma of the parotid gland, and adamantinoma and papillomas of the bladder (not shown) as well as for squamous cell carcinomas of skin, tongue, epiglottis, esophagus, cervix, and rectum (Fig. 5) . Metastatic lesions of squamous cell carcinoma in lymph nodes were also positive (not shown). Surrounding tumor-associated stromal tissue and blood vessels were negative. Desmoplakin staining in dotted arrays, showing typical apical enrichment, was characteristic ofadenocarcinomas of stomach and colon as well as metastatic lesions derived from them (Fig. 6) . Among (Scale bar = 20 ,Pm.) atin antibodies were also stained by desmoplakin antibodies such as hepatocellular carcinomas, cholangiocarcinomas, and other carcinomas metastatic to the liver (not shown). Strong punctate staining with anti-desmoplakin was also seen in ductal and lobular carcinomas of the breast (Fig. 7a) hum (Fig. 7b) . Poorly differentiated or undifferentiated carcinomas such as in lung, parotid gland, and bone were also positive.
Negative reaction with desmoplakin antibodies was observed in all cases ofnonepithelial tumors examined, including uterine leiomyomas and leiomyosarcomas and endometrial stromal sarcomas, rhabdomyosarcomas, fibrosarcomas, hemangiomas of the liver, centroblastic and lymphoblastic lymphomas, malignant fibrous histiocytomas, melanomas, and neuroblastomas. All tissues negative for desmoplakin were also negative for staining with antibodies to cytokeratins. DISCUSSION Desmoplakins I and II are large isoelectric polypeptides (Mr 250,000 and 215,000) which are the major constituent proteins of the desmosomal plaque (34) . Both polypeptides have been identified in epithelia from various species (34) , and the identity of desmoplakins I and II in various epithelia has been demonstrated by biochemical techniques (unpublished data). Antibodies to these proteins allow the specific detection of desmosomes and other structures containing desmosomal plaque material [hemidesmosomes, internalized desmosomal domains (28, 36)] but do not react with any other type of junction. Expression of desmoplakin correlates with the appearance of typical desmosomal ultrastructure and has been found only in epithelial cells and myocardium.
Because, in most epithelial cells, desmoplakins are among the major proteins (34) and show broad immunological crossspecies reactivity, indicating their conservation during evolution ofvertebrates, they are suitable markers for distinguishing epithelial (and myocardial) cells from other cell types and, consequently, carcinomas from other types ofmalignant neoplasms. Whether certain desmosome-like structures described in some kinds of tumors of unclear origin such as Ewing sarcoma and meningiomas of unclear cell character are related to desmosomes and contain desmoplakins remains to be seen. In addition, the combined use of antibodies to both independent molecular markers-cytokeratins and desmoplakins-makes it possible now to define epithelial and carcinoma cells by the concomitant expression of two characteristic major cytoskeletal proteins, irrespective of the morphological appearance of the specific cells. We propose that immunocytochemical studies with antibodies to desmoplakins, together with antibodies to cytokeratin already proven to be valuable in clinical diagnosis, be used for establishing the positive diagnosis or the exclusion of carcinoma in difficult or doubtful cases.
Antibodies to desmoplakins also can be used in pathological examinations of exfoliative preparations as has been shown for suspensions of cells from epithelia of urinary and genital tract as well as intestine (28) . Immunolocalization ofdesmoplakin further facilitates quantitation ofdesmosomal densities at the light microscope level and allows the detection of disorders and changes of desmosomal arrays on surfaces of normal and neoplastic cells.
